Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Ancient exercise shows promise for blood pressure control

NCT ID NCT05397535

Disease control Sponsor: China National Center for Cardiovascular Diseases Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study looked at whether Baduanjin, a gentle traditional exercise, can help lower blood pressure in people with high-normal readings. Over 200 adults aged 40 and older practiced Baduanjin for at least 30 minutes, five days a week, for a year. Researchers measured blood pressure changes at 12 and 52 weeks to see if this simple routine could be a practical way to manage blood pressure without medication.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Baduanjin exercise
What this could lead to
If it works, this could offer a simple, drug-free way to help control blood pressure and reduce heart disease risk.
What could go wrong
This is a small, completed study without a placebo control, so results may not be widely applicable. Exercise adherence and lifestyle factors could also affect outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

216 people

The number who actually took part.

Started

Jun 2022

Finished

Jul 2025

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

40 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 40 years or older; * Systolic blood pressure (SBP) \<140 mmHg and diastolic blood pressure (DBP) \<90 mmHg * SBP 130-139 mmHg, and/or DBP 85-89 mmHg Exclusion Criteria: * Diagnosis of hypertension (SBP≥140 mmHg, and/or DBP ≥90mmHg） * History of cardiovascular diseases, such as coronary heart disease, heart failure, stroke, and peripheral vascular disease * Diagnosis of chronic kidney disease, primary aldosteronism, Cushing's syndrome, or pheochromocytoma * Newly diagnosed cancer or cancer metastasis within 5 years * History of autoimmune disease * Having taken antihypertensive drugs or immunoregulators within 2 weeks * A long-term need for antihypertensive drugs or immunomoregulators * Unable to maintain moderate intensity exercise due to illness or other reasons * Pregnant, breastfeeding, or planning to become pregnant within the next 1 year * Currently taking regular exercise (at least 30 minutes of moderate-intensity exercise at least three times a week) * Allergic to sports bracelets * Having participated or been participating in other clinical trials within the last 3 months * Unable to use smartphones * Other factors that may affect the follow-up, such as alcohol or substance abuse in the last 12 months, planing to live out of town for a long time, or diagnosis of dementia or cognitive impairment which indicates incapability of completing the study * Unable to accurately measure blood pressure using the sphygmomanometer provided by the study due to a too large or too small arm circumference

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Elevated blood pressure are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

hypertensive disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Elevated blood pressure

Contacts and locations

Locations

  • Fuwai Hospital

    Beijing, Beijing Municipality, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.